Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

被引：0
|
作者：
Gunilla Journath
Kristina Hambraeus
Emil Hagström
Billie Pettersson
Mickael Löthgren
机构：
[1] Karolinska University Hospital,Cardiology unit, Department of Medicine, Karolinska Institutet
[2] Falun Hospital,Department of Cardiology
[3] Uppsala University,Uppsala Clinical Research Center, and Department of Medical Sciences
[4] Amgen Inc,undefined
[5] Thousand Oaks,undefined
[6] Amgen (Europe) GmbH,undefined
来源：
BMC Cardiovascular Disorders | / 17卷
关键词：
Cardiovascular disease; Costs; Guidelines; Lipids; Myocardial infarction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
    Simpson, Ross J., Jr.
    Signorovitch, James
    Birnbaum, Howard
    Ivanova, Jasmina
    Connolly, Cristina
    Kidolezi, Yohanne
    Kuznik, Andreas
    MAYO CLINIC PROCEEDINGS, 2009, 84 (12) : 1065 - 1072
  • [32] How to overcome barriers to the implementation of prevention and treatment strategies for atherosclerotic cardiovascular disease through lipid-lowering therapy
    Arca, Marcello
    Averna, Maurizio
    Borghi, Claudio
    Lettino, Maddalena
    Filardi, Pasquale Perrone
    Alberti, Antonia
    Bilato, Claudio
    Calabro, Paolo
    Carubbi, Francesca
    Ciccone, Marco Matteo
    Cipollone, Francesco
    Citroni, Nadia
    De Luca, Leonardo
    Giaccari, Andrea
    Iannuzzo, Gabriella
    Maloberti, Alessandro
    Marcucci, Rossella
    Spinazzola, Pasquale Pignatelli
    Pirro, Matteo
    Pisciotta, Livia
    Sarullo, Filippo
    Sciacqua, Angela
    Suppressa, Patrizia
    Varbella, Ferdinando
    Werba, Jose Pablo
    Zambon, Alberto
    GIORNALE ITALIANO DI CARDIOLOGIA, 2023, 24 (10) : 770 - 780
  • [33] Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular disease
    Gu, Jing
    Sanchez, Robert J.
    Chauhan, Ankita
    Fazio, Sergio
    Rosenson, Robert S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (06) : 901 - 905
  • [34] Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease
    Michos, Erin D.
    McEvoy, John W.
    Blumenthal, Roger S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1557 - 1567
  • [35] Androgen therapy and atherosclerotic cardiovascular disease
    McGrath, K-Cy
    McRobb, L. S.
    Heather, A. K.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (01) : 11 - 21
  • [36] Gene therapy for atherosclerotic cardiovascular disease
    Spodick, DH
    MAYO CLINIC PROCEEDINGS, 2000, 75 (11) : 1223 - 1223
  • [37] Chelation therapy for atherosclerotic cardiovascular disease
    Vanessa Villarruz-Sulit, Maria
    Forster, Rachel
    Dans, Antonio L.
    Tan, Flordeliza N.
    Sulit, Dennis, V
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (05):
  • [38] Antiplatelet therapy in atherosclerotic cardiovascular disease
    Gonzalez, ER
    CLINICAL THERAPEUTICS, 1998, 20 : B18 - B41
  • [39] Access to Nonstatin Lipid-Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease
    Knowles, Joshua W.
    Howard, William B.
    Karayan, Lala
    Baum, Seth J.
    Wilemon, Katherine A.
    Ballantyne, Christie M.
    Myers, Kelly D.
    CIRCULATION, 2017, 135 (22) : 2204 - 2206
  • [40] Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease
    Yawen Jiang
    Weiyi Ni
    PharmacoEconomics, 2019, 37 : 943 - 952
12345